Ras inhibitors and methods of use thereof

TW202641555APending Publication Date: 2026-10-16KESTREL THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115101658
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-10-14
Filing Date
2026-01-15
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001080949_001
    Figure TWG2TA001080949_001
  • Figure TWG2TA001080949_002
    Figure TWG2TA001080949_002
  • Figure TWG2TA001080949_003
    Figure TWG2TA001080949_003
Patent Text Reader

Abstract

The disclosure provides compounds, e.g., compounds of Formulae I through IX, and subformulae thereof, and their use in treating medical diseases or disorders, such as cancer. Pharmaceutical compositions and methods of making compounds of the disclosure are provided. The compounds are contemplated to be modulators of Ras (e.g., K-Ras).
Need to check novelty before this filing date? Find Prior Art